000 01068 a2200265 4500
005 20250515085920.0
264 0 _c20080116
008 200801s 0 0 eng d
022 _a1473-4877
024 7 _a10.1185/030079907x233142
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLeist, Thomas P
245 0 0 _aThe potential role for cladribine in the treatment of multiple sclerosis: clinical experience and development of an oral tablet formulation.
_h[electronic resource]
260 _bCurrent medical research and opinion
_cNov 2007
300 _a2667-76 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAdministration, Oral
650 0 4 _aCladribine
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aMultiple Sclerosis
_xdrug therapy
650 0 4 _aTablets
700 1 _aVermersch, Patrick
773 0 _tCurrent medical research and opinion
_gvol. 23
_gno. 11
_gp. 2667-76
856 4 0 _uhttps://doi.org/10.1185/030079907x233142
_zAvailable from publisher's website
999 _c17405348
_d17405348